HISTOGENICS CORP Business Finance Contracts & Agreements

74 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Supplement to Loan and Security Agreement among Ocugen, Inc., Ocugen OpCo, Inc., and Avenue Capital Entities (November 2024)
Loan Agreements
HISTOGENICS CORP
Biotechnology
CA
2025
Loan and Security Agreement among Ocugen, Inc., Ocugen OpCo, Inc., Avenue Capital Management II, L.P., and Avenue Venture Opportunities Funds (November 6, 2024)
Loan Agreements
HISTOGENICS CORP
Biotechnology
CA
2025
Subscription Agreement between Ocugen, Inc. and Avenue Venture Opportunities Funds
Subscription Agreements
HISTOGENICS CORP
Biotechnology
2025
Underwriting Agreement between Ocugen, Inc. and Titan Partners Group LLC (July 31, 2024)
Underwriting Agreements
HISTOGENICS CORP
Biotechnology
NY
2024
Ocugen, Inc. 2019 Equity Incentive Plan Performance Restricted Stock Unit Grant Agreement with Participant
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
DE
2024
Ocugen, Inc. Underwriting Agreement with Cantor Fitzgerald & Co. for 30,000,000 Shares of Common Stock
Underwriting Agreements
HISTOGENICS CORP
Biotechnology
NY
2023
Second Amendment to Co-Development and Commercialization Agreement between Ocugen, Inc. and CanSino Biologics Inc.
Modification Agreements
HISTOGENICS CORP
Biotechnology
2023
Ocugen, Inc. Restricted Stock Unit Inducement Award Agreement
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
DE
2023
Ocugen, Inc. Non-Qualified Stock Option Inducement Award Agreement with Employee
Warrant Agreements
HISTOGENICS CORP
Biotechnology
DE
2023
Ocugen, Inc. Non-Qualified Stock Option Agreement with Individual Optionee
Warrant Agreements
HISTOGENICS CORP
Biotechnology
DE
2023
At Market Issuance Sales Agreement between Ocugen, Inc. and Cantor Fitzgerald & Co., Mizuho Securities USA LLC, H.C. Wainwright & Co., Roth Capital Partners, LLC, and Chardan...
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
NY
2022
Common Stock Purchase Warrant Agreement between Ocugen, Inc. and Liminal BioSciences Inc.
Warrant Agreements
HISTOGENICS CORP
Biotechnology
2022
Description of Ocugen, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
2022
Underwriting Agreement between Ocugen, Inc. and Cantor Fitzgerald & Co. for Sale of Common Stock
Underwriting Agreements
HISTOGENICS CORP
Biotechnology
NY
2022
Ocugen, Inc. Stock Option Agreement with Individual Optionee
Stock Agreements
HISTOGENICS CORP
Biotechnology
2021
First Amendment to Co-Development, Supply and Commercialization Agreement between Ocugen, Inc. and Bharat Biotech International Limited
Modification Agreements
HISTOGENICS CORP
Biotechnology
2021
Ocugen, Inc. 2019 Equity Incentive Plan Performance-Vested Stock Option Agreement
Warrant Agreements
HISTOGENICS CORP
Biotechnology
2021
Securities Purchase Agreement between Ocugen, Inc. and Purchasers dated April 23, 2021
Purchase Agreements
HISTOGENICS CORP
Biotechnology
NY
2021
Ocugen, Inc. Common Stock Purchase Warrant Agreement
Warrant Agreements
HISTOGENICS CORP
Biotechnology
2021
Description of Ocugen, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
2021
Securities Purchase Agreement between Ocugen, Inc. and Purchasers (February 7, 2021)
Purchase Agreements
HISTOGENICS CORP
Biotechnology
NY
2021
At Market Issuance Sales Agreement between Ocugen, Inc. and Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc.
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Controlled Equity Offering Sales Agreement between Ocugen, Inc. and Cantor Fitzgerald & Co. (June 12, 2020)
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Controlled Equity Offering Sales Agreement between Ocugen, Inc. and Cantor Fitzgerald & Co. dated May 8, 2020
Equity Distribution Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Paycheck Protection Program Promissory Note between Ocugen, Inc. and Silicon Valley Bank (April 30, 2020)
Note Agreements
HISTOGENICS CORP
Biotechnology
2020
Ocugen, Inc. Senior Note Agreement Dated April 22, 2020
Note Agreements
HISTOGENICS CORP
Biotechnology
PA
2020
Amendment and Exchange Agreement among Ocugen, Inc., Ocugen OpCo, Inc., and Investor (April 22, 2020)
Exchange Agreements
HISTOGENICS CORP
Biotechnology
NY
2020
Ocugen, Inc. Stock Option Agreement with Optionee under 2019 Equity Incentive Plan
Stock Agreements
HISTOGENICS CORP
Biotechnology
2020
Ocugen, Inc. Stock Option Agreement under 2019 Equity Incentive Plan
Warrant Agreements
HISTOGENICS CORP
Biotechnology
2020
Description of Ocugen, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
HISTOGENICS CORP
Biotechnology
2020
Amendment to Warrants to Purchase Common Stock between Ocugen, Inc. and Holder (November 5, 2019)
Warrant Agreements
HISTOGENICS CORP
Biotechnology
2019
Amendment No. 2 to Asset Purchase Agreement between Medavate Corp. and Ocugen, Inc.
Purchase Agreements
HISTOGENICS CORP
Biotechnology
DE
2019
Ocugen, Inc. Series C Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
HISTOGENICS CORP
Biotechnology
NY
2019
Ocugen, Inc. Series B Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
HISTOGENICS CORP
Biotechnology
NY
2019
Ocugen, Inc. Series A Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
HISTOGENICS CORP
Biotechnology
NY
2019
Amendment No. 1 to Asset Purchase Agreement between Medavate Corp. and Histogenics Corporation
Modification Agreements
HISTOGENICS CORP
Biotechnology
DE
2019
Amendment to Securities Purchase Agreement among Ocugen, Inc., Histogenics Corporation, and Investor (June 28, 2019)
Purchase Agreements
HISTOGENICS CORP
Biotechnology
NY
2019
Security Agreement, dated as of May 21, 2019, by Ocugen, Inc. in favor of HB Fund LLC, in its capacity as collateral agent for the investors party to the Securities Purchase...
Purchase Agreements
HISTOGENICS CORP
Biotechnology
2019
Form of Senior Secured Convertible Note, dated as of May 21, 2019, by Ocugen, Inc. to each of the investors party to the Securities Purchase Agreement, dated as of May 21, 2019
Note Agreements
HISTOGENICS CORP
Biotechnology
NY
2019
Securities Purchase Agreement, dated as of May 21, 2019, by and among Ocugen, Inc. and the investors party thereto
Purchase Agreements
HISTOGENICS CORP
Biotechnology
NY
2019